Glaukos officer proposes $101K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GLAUKOS Corp officer Tomas Navratil reported a proposed sale of 1,031 common shares, with an aggregate market value of $101,027.69 and an approximate sale date of March 16, 2026. The listed acquisition history shows 259 common shares acquired through restricted stock vesting on December 27, 2024, and 772 on January 1, 2025. The notice lists December 15, 2025 as the plan-adoption or instruction date for reliance on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Vesting financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.